electroCore, Inc.
F:43E
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
electroCore, Inc.
F:43E
|
US |
|
S
|
Shoprite Holdings Ltd
SWB:HY7
|
ZA |
|
C
|
Canopy Growth Corp
NASDAQ:CGC
|
CA |
|
S
|
SK Hynix Inc
XMUN:HY9H
|
KR |
|
A
|
Analog Devices Inc
SWB:ANL
|
US |
|
Z
|
Zurich Insurance Group AG
SWB:ZFIN
|
CH |
|
Novartis AG
SIX:NOVN
|
CH |
|
A
|
Aluminum Corp of China Ltd
F:AOCA
|
CN |
electroCore, Inc.
electroCore is a medical device company that sells non-invasive nerve stimulation products. Its main device line uses mild electrical pulses on the neck to stimulate the vagus nerve, which is a signal pathway connected to pain, migraine, and other body functions. The company’s products are used by patients under a doctor’s guidance, and they are designed to offer a drug-free treatment option for certain conditions. The company makes money by selling or leasing its devices and by selling disposable treatment supplies and related accessories. Its main customers include patients, physicians, clinics, and health systems that look for non-drug therapies for migraine and some other neurological or pain-related uses. electroCore also works with payers and care providers, since coverage and reimbursement can affect how easily patients adopt these treatments. What makes electroCore’s business different is that it sits at the intersection of medical devices and therapy delivery. Instead of selling a pill or a one-time procedure, it sells a repeat-use treatment system that depends on both clinical adoption and patient use at home. That gives the company a mix of device sales and recurring product revenue, while tying its fortunes to the broader move toward non-opioid and non-invasive care.
electroCore is a medical device company that sells non-invasive nerve stimulation products. Its main device line uses mild electrical pulses on the neck to stimulate the vagus nerve, which is a signal pathway connected to pain, migraine, and other body functions. The company’s products are used by patients under a doctor’s guidance, and they are designed to offer a drug-free treatment option for certain conditions.
The company makes money by selling or leasing its devices and by selling disposable treatment supplies and related accessories. Its main customers include patients, physicians, clinics, and health systems that look for non-drug therapies for migraine and some other neurological or pain-related uses. electroCore also works with payers and care providers, since coverage and reimbursement can affect how easily patients adopt these treatments.
What makes electroCore’s business different is that it sits at the intersection of medical devices and therapy delivery. Instead of selling a pill or a one-time procedure, it sells a repeat-use treatment system that depends on both clinical adoption and patient use at home. That gives the company a mix of device sales and recurring product revenue, while tying its fortunes to the broader move toward non-opioid and non-invasive care.
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
